Porphyromonas Denticanis-Gulae-Salivosa Bacterin*(Porphyromonas Vaccine)
Product Description
The Porphyromonas Denticanis-Gulae-Salivosa Bacterin is approved for the vaccination of
healthy dogs as an aid in preventing periodontitis, as demonstrated by a reduction in
bone changes (osteolysis/osteosclerosis).
Advantages
- Porphyromonas Denticanis-Gulae-Salivosa Bacterin is the first and only vaccine to
aid in the prevention of canine periodontitis which affects 85% of dogs over 3 years of
age.1
- This product is an important new adjunct to professional dental cleaning,
periodontal therapy and owner-administrated dental care routines.
- The Porphyromonas Vaccine is part of a complete canine wellness program that
encourages annual visits.
- Safety of the vaccine was evaluated in laboratory studies and a field safety study.
Key Features
- Inactivated P. denticanis, P. gulae and P. salivosa bacterin (liquid form)
- Adjuvant to enhance immune response
- Primary vaccination—two doses, three week apart
- Twenty-five 1 mL doses per carton
- Adminster 1 mL subcutaneously
Directions
- General Directions: Vaccination of healthy dogs is recommended. Shake well.
Aspetically administer 1 mL subcutaneously.
- Primary Vaccination: Healthy dogs should receive 2 doses administered 3 weeks apart.
- Revaccination: Duration of immunity for this product has not been determined; six
and twelve month intervals are being evaluated.
* Notice: This product license is conditional. Efficacy and/or potency of this product
have not been fully demonstrated, consultation with a veterinarian is recommended.
1. Beard G, Emily P, Milligan & Williams C: American Animal Hospital Association,
Veterinary Dentistry, Course 1, 1989.
Product Information
Material Safety Data Sheet
Back to top
entire article (printer friendly)